Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer.

Wang X, Ramamurthy G, Shirke AA, Walker E, Mangadlao J, Wang Z, Wang Y, Shan L, Schluchter MD, Dong Z, Brady-Kalnay SM, Walker NK, Gargesha M, MacLennan G, Luo D, Sun R, Scott B, Roy D, Li J, Basilion JP.

Cancer Res. 2020 Jan 15;80(2):156-162. doi: 10.1158/0008-5472.CAN-19-0201. Epub 2019 Nov 12.

PMID:
31719100
2.

Validating the New Primary Care Measure in the Medical Expenditure Panel Survey.

Olaisen RH, Flocke SA, Smyth KA, Schluchter MD, Koroukian SM, Stange KC.

Med Care. 2020 Jan;58(1):52-58. doi: 10.1097/MLR.0000000000001220.

PMID:
31688557
3.

Developing a New Measure of Primary Care Using the Medical Expenditure Panel Survey.

Olaisen RH, Flocke SA, Smyth KA, Schluchter MD, Koroukian SM, Stange KC.

Med Care. 2019 Jun;57(6):475-481. doi: 10.1097/MLR.0000000000001125.

PMID:
31033849
4.

Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study.

Cummings Iii KC, Kou TD, Chak A, Schluchter MD, Margevicius S, Cooper GS, Meropol NJ, Perry Y, Linden PA, Cummings LC.

PLoS One. 2019 Jan 22;14(1):e0211125. doi: 10.1371/journal.pone.0211125. eCollection 2019. Erratum in: PLoS One. 2019 Mar 21;14(3):e0214528.

5.

Human and Rat Bone Marrow-Derived Mesenchymal Stem Cells Differ in Their Response to Fibroblast Growth Factor and Platelet-Derived Growth Factor.

Lennon D, Solchaga LA, Somoza RA, Schluchter MD, Margevicius S, Caplan AI.

Tissue Eng Part A. 2018 Dec;24(23-24):1831-1843. doi: 10.1089/ten.TEA.2018.0126. Epub 2018 Aug 22.

6.

Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis.

Schluchter MD, Piccorelli AV.

Stat Methods Med Res. 2019 May;28(5):1489-1507. doi: 10.1177/0962280218764193. Epub 2018 Apr 4.

7.

Effect of Pericardial Fat Volume and Density on Markers of Insulin Resistance and Inflammation in Patients With Human Immunodeficiency Virus Infection.

Longenecker CT, Margevicius S, Liu Y, Schluchter MD, Yun CH, Bezerra HG, McComsey GA.

Am J Cardiol. 2017 Oct 15;120(8):1427-1433. doi: 10.1016/j.amjcard.2017.07.019. Epub 2017 Jul 24.

8.

Diagnostic performance of an automated analysis software for the diagnosis of Alzheimer's dementia with 18F FDG PET.

Partovi S, Yuh R, Pirozzi S, Lu Z, Couturier S, Grosse U, Schluchter MD, Nelson A, Jones R, O'Donnell JK, Faulhaber P.

Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):12-23. eCollection 2017.

9.

Cancer preventive services, socioeconomic status, and the Affordable Care Act.

Cooper GS, Kou TD, Dor A, Koroukian SM, Schluchter MD.

Cancer. 2017 May 1;123(9):1585-1589. doi: 10.1002/cncr.30476. Epub 2017 Jan 9.

10.

Expression of miR-145-5p During Chondrogenesis of Mesenchymal Stem Cells.

Verbus EA, Kenyon JD, Sergeeva O, Awadallah A, Yuan L, Welter JF, Caplan AI, Schluchter MD, Khalil AM, Lee Z.

J Stem Cell Res (Overl Park). 2017;1(3):1-10. Epub 2017 Oct 3.

11.

Rapid visualization of nonmelanoma skin cancer.

Walker E, Mann M, Honda K, Vidimos A, Schluchter MD, Straight B, Bogyo M, Popkin D, Basilion JP.

J Am Acad Dermatol. 2017 Feb;76(2):209-216.e9. doi: 10.1016/j.jaad.2016.09.008. Epub 2016 Nov 19.

12.

Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population.

Cummings LC, Kou TD, Schluchter MD, Chak A, Cooper GS.

Gastrointest Endosc. 2016 Aug;84(2):232-240.e1. doi: 10.1016/j.gie.2016.01.019. Epub 2016 Jan 19.

13.

Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.

Meropol NJ, Wong YN, Albrecht T, Manne S, Miller SM, Flamm AL, Benson AB 3rd, Buzaglo J, Collins M, Egleston B, Fleisher L, Katz M, Kinzy TG, Liu TM, Margevicius S, Miller DM, Poole D, Roach N, Ross E, Schluchter MD.

J Clin Oncol. 2016 Feb 10;34(5):469-78. doi: 10.1200/JCO.2015.63.2257. Epub 2015 Dec 23.

14.

Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.

Wong YN, Schluchter MD, Albrecht TL, Benson AB 3rd, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ.

J Clin Oncol. 2016 Feb 10;34(5):479-87. doi: 10.1200/JCO.2015.63.2463. Epub 2015 Dec 23.

15.

Changes in Receipt of Cancer Screening in Medicare Beneficiaries Following the Affordable Care Act.

Cooper GS, Kou TD, Schluchter MD, Dor A, Koroukian SM.

J Natl Cancer Inst. 2015 Dec 6;108(5). pii: djv374. doi: 10.1093/jnci/djv374. Print 2016 May.

16.

Music-based magnetic resonance fingerprinting to improve patient comfort during MRI examinations.

Ma D, Pierre EY, Jiang Y, Schluchter MD, Setsompop K, Gulani V, Griswold MA.

Magn Reson Med. 2016 Jun;75(6):2303-14. doi: 10.1002/mrm.25818. Epub 2015 Jul 16.

17.

Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer.

Meyers JD, Cheng Y, Broome AM, Agnes RS, Schluchter MD, Margevicius S, Wang X, Kenney ME, Burda C, Basilion JP.

Part Part Syst Charact. 2015 Apr;32(4):448-457.

18.

Free-breathing liver perfusion imaging using 3-dimensional through-time spiral generalized autocalibrating partially parallel acquisition acceleration.

Chen Y, Lee GR, Wright KL, Badve C, Nakamoto D, Yu A, Schluchter MD, Griswold MA, Seiberlich N, Gulani V.

Invest Radiol. 2015 Jun;50(6):367-75. doi: 10.1097/RLI.0000000000000135.

19.

Towards the feasibility of using ultrasound to determine mechanical properties of tissues in a bioreactor.

Mansour JM, Gu DW, Chung CY, Heebner J, Althans J, Abdalian S, Schluchter MD, Liu Y, Welter JF.

Ann Biomed Eng. 2014 Oct;42(10):2190-202. doi: 10.1007/s10439-014-1079-4. Epub 2014 Aug 5.

20.

Diverticulosis and the risk of interval colorectal cancer.

Cooper GS, Xu F, Schluchter MD, Koroukian SM, Barnholtz Sloan JS.

Dig Dis Sci. 2014 Nov;59(11):2765-72. doi: 10.1007/s10620-014-3246-8. Epub 2014 Jun 14.

21.

Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.

Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR.

AJNR Am J Neuroradiol. 2014 Oct;35(10):1970-5. doi: 10.3174/ajnr.A3993. Epub 2014 Jun 12.

22.

Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.

Kershah S, Partovi S, Traughber BJ, Muzic RF Jr, Schluchter MD, O'Donnell JK, Faulhaber P.

Mol Imaging Biol. 2013 Dec;15(6):776-85. doi: 10.1007/s11307-013-0629-8.

23.

Use of colonoscopy for polyp surveillance in Medicare beneficiaries.

Cooper GS, Kou TD, Barnholtz Sloan JS, Koroukian SM, Schluchter MD.

Cancer. 2013 May 15;119(10):1800-7. doi: 10.1002/cncr.27990. Epub 2013 Feb 21.

24.

The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells.

Lennon DP, Schluchter MD, Caplan AI.

Stem Cells Transl Med. 2012 Apr;1(4):279-88. doi: 10.5966/sctm.2011-0011. Epub 2012 Apr 2.

25.

Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis.

Piccorelli AV, Schluchter MD.

Stat Med. 2012 Dec 20;31(29):3931-45. doi: 10.1002/sim.5469. Epub 2012 Jul 11.

26.

Prevalence and predictors of interval colorectal cancers in medicare beneficiaries.

Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM.

Cancer. 2012 Jun 15;118(12):3044-52. doi: 10.1002/cncr.26602. Epub 2011 Oct 11.

27.

TREATMENT AND SURVIVAL PATTERNS IN RELATION TO MULTIMORBIDITY IN PATIENTS WITH LOCOREGIONAL BREAST AND COLORECTAL CANCER.

Koroukian SM, Bakaki PM, Schluchter MD, Owusu C.

J Geriatr Oncol. 2011 Jul;2(3):200-208.

28.

Nondestructive evaluation of hydrogel mechanical properties using ultrasound.

Walker JM, Myers AM, Schluchter MD, Goldberg VM, Caplan AI, Berilla JA, Mansour JM, Welter JF.

Ann Biomed Eng. 2011 Oct;39(10):2521-30. doi: 10.1007/s10439-011-0351-0. Epub 2011 Jul 20.

29.

Management of malignant colonic polyps: a population-based analysis of colonoscopic polypectomy versus surgery.

Cooper GS, Xu F, Barnholtz Sloan JS, Koroukian SM, Schluchter MD.

Cancer. 2012 Feb 1;118(3):651-9. doi: 10.1002/cncr.26340. Epub 2011 Jul 12.

30.

Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system.

Lee RG, Vecchiotti MA, Heaphy J, Panneerselvam A, Schluchter MD, Oleinick NL, Lavertu P, Alagramam KN, Arnold JE, Sprecher RC.

Laryngoscope. 2010 Mar;120(3):618-24. doi: 10.1002/lary.20709.

31.

Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.

Barr PM, Lazarus HM, Cooper BW, Schluchter MD, Panneerselvam A, Jacobberger JW, Hsu JW, Janakiraman N, Simic A, Dowlati A, Remick SC.

Am J Hematol. 2009 Aug;84(8):484-7. doi: 10.1002/ajh.21449.

32.

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.

Brell JM, Krishnamurthi SS, Javle M, Saltzman J, Wollner I, Pelley R, Dowlati A, Kantharaj BN, Schluchter MD, Rath L, Ivy SP, Remick SC.

Cancer Chemother Pharmacol. 2009 Apr;63(5):851-7. doi: 10.1007/s00280-008-0807-6. Epub 2008 Aug 1.

33.

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

Krishnamurthi SS, Brell JM, Hoppel CL, Egorin MJ, Weaver KC, Li X, Ingalls ST, Zuhowski EG, Schluchter MD, Dowlati A, Cooney MM, Gibbons J, Overmoyer BA, Ivy SP, Remick SC.

Cancer Chemother Pharmacol. 2009 Feb;63(3):441-50. doi: 10.1007/s00280-008-0754-2. Epub 2008 Apr 15.

34.

Flexible Approaches to Computing Mediated Effects in Generalized Linear Models: Generalized Estimating Equations and Bootstrapping.

Schluchter MD.

Multivariate Behav Res. 2008 Apr-Jun;43(2):268-88. doi: 10.1080/00273170802034877.

PMID:
26765663
35.

Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4.

Ke MS, Xue LY, Feyes DK, Azizuddin K, Baron ED, McCormick TS, Mukhtar H, Panneerselvam A, Schluchter MD, Cooper KD, Oleinick NL, Stevens SR.

Photochem Photobiol. 2008 Mar-Apr;84(2):407-14. doi: 10.1111/j.1751-1097.2007.00278.x. Epub 2008 Jan 23. Erratum in: Photochem Photobiol. 2008 May-Jun;84(3):819.

PMID:
18221452
36.

Molecular classification of thyroid nodules by cytology.

Pagedar NA, Chen DH, Wasman JK, Savvides P, Schluchter MD, Wilhelm SM, Lavertu P.

Laryngoscope. 2008 Apr;118(4):692-6.

PMID:
18094649
37.

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.

Konstan MW, Schluchter MD, Xue W, Davis PB.

Am J Respir Crit Care Med. 2007 Dec 1;176(11):1084-9. Epub 2007 Sep 13.

38.

Specific molds associated with asthma in water-damaged homes.

Vesper SJ, McKinstry C, Yang C, Haugland RA, Kercsmar CM, Yike I, Schluchter MD, Kirchner HL, Sobolewski J, Allan TM, Dearborn DG.

J Occup Environ Med. 2006 Aug;48(8):852-8.

PMID:
16902378
39.

Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data.

Schluchter MD, Konstan MW, Drumm ML, Yankaskas JR, Knowles MR.

Am J Respir Crit Care Med. 2006 Oct 1;174(7):780-6. Epub 2006 Jul 20.

40.

Mouse as a model of growth retardation in cystic fibrosis.

Rosenberg LA, Schluchter MD, Parlow AF, Drumm ML.

Pediatr Res. 2006 Feb;59(2):191-5.

PMID:
16439577
41.

Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.

van Heeckeren AM, Schluchter MD, Xue W, Davis PB.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):288-96. Epub 2005 Nov 4.

42.

Genetic modifiers of lung disease in cystic fibrosis.

Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR; Gene Modifier Study Group.

N Engl J Med. 2005 Oct 6;353(14):1443-53.

43.

Shared parameter models for the joint analysis of longitudinal data and event times.

Vonesh EF, Greene T, Schluchter MD.

Stat Med. 2006 Jan 15;25(1):143-63.

PMID:
16025541
44.

Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.

John CC, Moormann AM, Pregibon DC, Sumba PO, McHugh MM, Narum DL, Lanar DE, Schluchter MD, Kazura JW.

Am J Trop Med Hyg. 2005 Jul;73(1):222-8.

PMID:
16014863
45.

Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry.

Stoller JK, Tomashefski J Jr, Crystal RG, Arroliga A, Strange C, Killian DN, Schluchter MD, Wiedemann HP.

Chest. 2005 Apr;127(4):1196-204.

PMID:
15821195
46.

Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.

Hart MA, Konstan MW, Darrah RJ, Schluchter MD, Storfer-Isser A, Xue L, Londono D, Goddard KA, Drumm ML.

Pediatr Pulmonol. 2005 Jun;39(6):544-50.

PMID:
15806595
47.
48.

Successful techniques for retaining a cohort of infants and children born to HIV-infected women: the prospective P2C2 HIV study.

Geromanos K, Sunkle SN, Mauer MB, Carp D, Ancker J, Zhang W, Easley KA, Schluchter MD, Kozinetz CA, Mellins RB.

J Assoc Nurses AIDS Care. 2004 Jul-Aug;15(4):48-57.

49.

Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis.

Davis PB, Schluchter MD, Konstan MW.

Pediatr Pulmonol. 2004 Sep;38(3):204-9.

PMID:
15274098
50.

Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice.

van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB.

Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L944-52. Epub 2004 Jul 9.

Supplemental Content

Loading ...
Support Center